automeasure modules (Carl Zeiss)
Carl Zeiss is a verified supplier 
Carl Zeiss manufactures this product 
93
Structured Review
Carl Zeiss
automeasure modules
Automeasure Modules, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automeasure+module/AxioVision+4+Module+AutoMeasure/pm41455700-387-30-37
Average 93 stars, based on 19 article reviews
Automeasure Modules, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automeasure+module/AxioVision+4+Module+AutoMeasure/pm41455700-387-30-37
Average 93 stars, based on 19 article reviews
automeasure modules - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Imaging:Article Title: Effects of BACE1 Haploinsufficiency on APP Processing and Aβ Concentrations in Male and Female 5XFAD Alzheimer Mice at Different Disease Stages Article Snippet: Light microscopy was conducted on an Axioskop 2 microscope equipped with an AxioCaM HRc digital camera (Zeiss, Oberkochen, Germany) for capturing images. .. Semi-quantitative analysis was performed using AxioVision imaging software with the Article Title: Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy. Article Snippet: Rationale The β-secretase BACE1 initiates amyloid-β (Aβ) generation and represents a long-standing prime therapeutic target for the treatment of Alzheimer’s disease (AD).. However, BACE1 inhibitors tested to date in clinical trials have yielded no beneficial outcomes.. In fact, prior BACE1 inhibitor trials targeted at ~ 50–90% Aβ reductions in symptomatic or prodromal AD stages have ended in the discontinuation due to futility and/or side effects, including cognitive worsening rather than expected improvement at the highest dose. Software:Article Title: Effects of BACE1 Haploinsufficiency on APP Processing and Aβ Concentrations in Male and Female 5XFAD Alzheimer Mice at Different Disease Stages Article Snippet: Light microscopy was conducted on an Axioskop 2 microscope equipped with an AxioCaM HRc digital camera (Zeiss, Oberkochen, Germany) for capturing images. .. Semi-quantitative analysis was performed using AxioVision imaging software with the Article Title: A background Ca 2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling Article Snippet: .. Quantification of interstitial cardiac fibrosis was performed with the Article Title: Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy. Article Snippet: Rationale The β-secretase BACE1 initiates amyloid-β (Aβ) generation and represents a long-standing prime therapeutic target for the treatment of Alzheimer’s disease (AD).. However, BACE1 inhibitors tested to date in clinical trials have yielded no beneficial outcomes.. In fact, prior BACE1 inhibitor trials targeted at ~ 50–90% Aβ reductions in symptomatic or prodromal AD stages have ended in the discontinuation due to futility and/or side effects, including cognitive worsening rather than expected improvement at the highest dose. Cell Counting:Article Title: Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat. Article Snippet: Accepted Manuscript Research report Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat Young G. Hwang, Hyun S. Lee PII: S0006-8993(18)30173-2 DOI: https://doi.org/10.1016/j.brainres.2018.03.032 Reference: BRES 45735 To appear in: Brain Research Received Date: 1 November 2017 Revised Date: 15 March 2018 Accepted Date: 27 March 2018 Please cite this article as: Y.G.. Hwang, H.S.. Lee, Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat, Brain Research (2018), doi: https://doi.org/10.1016/j.brainres.2018.03.032 This is a PDF file of an unedited manuscript that has been accepted for publication. Labeling:Article Title: Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat. Article Snippet: Accepted Manuscript Research report Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat Young G. Hwang, Hyun S. Lee PII: S0006-8993(18)30173-2 DOI: https://doi.org/10.1016/j.brainres.2018.03.032 Reference: BRES 45735 To appear in: Brain Research Received Date: 1 November 2017 Revised Date: 15 March 2018 Accepted Date: 27 March 2018 Please cite this article as: Y.G.. Hwang, H.S.. Lee, Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat, Brain Research (2018), doi: https://doi.org/10.1016/j.brainres.2018.03.032 This is a PDF file of an unedited manuscript that has been accepted for publication. |